(Q50513031)

English

Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy

scientific article published in September 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Two-year results of photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

author name string

Moosang Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Kookyoung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Do Gyun Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Seung-Young Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Hyung-Woo Kwak

5

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

226

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

205-213

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Indocyanine green angiography and idiopathic polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Idiopathic polypoidal choroidal vasculopathy of the macula

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Photodynamic therapy combined with intravitreal injection of vascular endothelial growth factor antibody for polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Polypoidal choroidal vasculopathy: an angiographic discussion

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy

1 reference

https://api.crossref.org/works/10.1159%2F000330793

21 January 2018

Identifiers

10.1159/000330793

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/21893965

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50513031&oldid=2251857672"